Stage IIIB Breast Cancer Completed Phase 1 Trials for Celecoxib (DB00482)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070057Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerTreatment